company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,323333000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,323333000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,79576000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,79576000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,243757000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12485000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18309000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1984000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32778000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,210979000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,210997000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,79484000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,131513000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,131513000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,131485000.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61008015.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.16
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63865678.0
Impax Laboratories Inc,IPXL,,0001003642,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 17:05:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,108651000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,108651000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50114000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50114000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58537000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16579000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19490000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1774000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37843000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20694000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,321000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,308000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21002000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7144000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13858000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13858000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-5000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13863000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63390527.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67044266.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63000000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:58:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,125860000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,125860000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,66158000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,66158000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,59702000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15509000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23978000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2209000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41696000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18006000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,290000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-545000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-266000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17740000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5214000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12526000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12526000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-24000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12550000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64024483.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67654047.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62800000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 17:00:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,119849000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,119849000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,57195000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,57195000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62654000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16318000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18839000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2114000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37271000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25383000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,53000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,268000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,69000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,284000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25667000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8486000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17181000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17181000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-39000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17220000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64387413.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66986758.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63800000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 17:38:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,158559000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,158559000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,81157000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,81157000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77402000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20071000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20394000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1409000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41874000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35528000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,77000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,270000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2019000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1826000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33702000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11772000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21930000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21930000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,68000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21862000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64126855.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.33
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67319989.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64200000.0
Impax Laboratories Inc,IPXL,,0001003642,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.33
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,128568000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,128568000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,66015000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,66015000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62553000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21233000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18816000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4038000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44087000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18466000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,255000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-48000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,168000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18634000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6269000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12365000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12365000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12365000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65122240.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67907263.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65100000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:16:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,166460000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,166460000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,88637000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,88637000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77823000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24870000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19869000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2914000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47653000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30170000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,423000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,244000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-236000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29934000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11262000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18672000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18672000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18672000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65482700.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67954573.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64400000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 09:06:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145587000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145587000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,67560000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,67560000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78027000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28927000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20012000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-371000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48568000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29459000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,145000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,272000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,86000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,213000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29672000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9635000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20037000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20037000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20037000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65797722.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68366849.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66800000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 09:07:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,141077000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,141077000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,76926000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,76926000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64151000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33440000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22623000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3191000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59254000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4897000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,318000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-119000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,174000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5071000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,272000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4799000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4799000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4799000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65660271.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68404551.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65700000.0
Impax Laboratories Inc,IPXL,,0001003642,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148489000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148489000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90618000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90618000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57871000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29717000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19605000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4278000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53600000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4271000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,283000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,276000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,149456000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,149449000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,153720000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48278000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105442000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,105442000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,105442000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66487470.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.59
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68178355.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.55
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66300000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 09:11:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.59
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,129631000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,129631000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,70744000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,70744000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58887000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33275000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15540000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4304000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53119000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5768000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,315000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2997000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3267000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9035000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3416000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5619000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5619000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5619000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66748864.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68287948.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70200000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 16:59:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132641000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132641000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,84299000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,84299000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48342000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27968000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16071000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4497000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48536000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-194000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,50000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,349000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-85000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,214000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-180000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-180000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-180000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67051121.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67051121.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 17:20:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100741000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100741000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,66541000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,66541000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34200000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29328000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17638000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3466000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50432000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16232000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,359000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,397000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15835000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6213000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9622000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9622000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9622000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66921181.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68655038.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67100000.0
Impax Laboratories Inc,IPXL,,0001003642,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,118718000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,118718000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61096000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61096000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57622000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25477000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21741000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2173000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49391000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8231000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,388000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,76000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,399000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8630000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2205000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6425000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6425000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6425000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67702296.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69938872.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71400000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:49:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,157999000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,157999000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,73561000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,73561000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84438000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38888000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18756000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1293000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58937000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25501000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,370000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,353000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25854000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10117000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15737000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15737000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15737000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68254327.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70715226.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68400000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:03:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,131211000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,131211000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,70390000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,70390000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60821000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42208000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16893000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,572000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59673000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1148000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,350000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,198000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,502000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1650000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1530000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,120000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,120000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,120000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68186000.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70530349.0
Impax Laboratories Inc,IPXL,,0001003642,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68300000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143096000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143096000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,83862000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,0.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,83862000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,59234000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50160000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14962000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,960000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66082000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6848000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3975000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-166000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3857000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10705000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4372000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6333000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6333000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6333000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68968000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68968000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70400000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:30:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,214182000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,214182000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129331000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129331000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84851000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48309000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16995000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1494000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66798000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18053000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23856000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,294000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,961000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22601000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4548000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2696000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1852000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1852000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1852000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69339000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69338789.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61700000.0
Impax Laboratories Inc,IPXL,,0001003642,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:43:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,225508000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,225508000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,122918000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,122918000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102590000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19022000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,44298000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1319000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64639000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37951000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8331000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,333000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-47447000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-55445000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17494000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7086000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10408000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10408000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10408000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70665394.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70665000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69400000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:07:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,172590000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,172590000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99606000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99606000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72984000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44908000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21746000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1929000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68583000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4401000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8454000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,340000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-237000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8351000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3950000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1249000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2701000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2701000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2701000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71100123.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71100000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67500000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,227909000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,227909000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,393469000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,393469000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-165560000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55038000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48885000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3279000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107202000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-272628000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11089000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,222000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-239000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11106000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-283868000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-104531000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-179337000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-179337000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-179337000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71331247.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.51
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71331247.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.51
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71400000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:10:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.51
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,198422000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,198422000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-129094000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-129094000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,327516000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,101884000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-9187000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-44298000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,541597000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1292000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,591288000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-263906000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12545000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-895000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-368109000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-381549000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-645321000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8572000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-653893000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,374308000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-279585000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-279585000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71147397.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.93
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71147000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.93
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71200000.0
Impax Laboratories Inc,IPXL,,0001003642,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.93
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,184403000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,184403000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,159512000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,159512000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24891000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47055000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28568000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1072000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76695000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51804000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14441000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1285000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15726000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67530000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30900000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98430000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98431000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-98431000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71594000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.37
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71594472.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.37
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71800000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:11:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.37
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,202082000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,202082000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129676000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129676000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72406000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51615000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26847000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1170000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79632000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7226000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13369000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,155000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-497000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13711000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20937000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-520000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20417000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20417000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20417000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71804000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71803920.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72900000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,206392000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,206392000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,172336000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,172336000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34056000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53585000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15821000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1640000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71046000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37013000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13636000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,336000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2101000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15401000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52414000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3045000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49369000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49369000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49369000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71924592.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71924592.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71500000.0
Impax Laboratories Inc,IPXL,,0001003642,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 16:10:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,142355000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,142355000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,112075000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,112075000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30280000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57323000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12296000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,85537000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,155156000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-124876000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13692000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,346000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13346000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-138222000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7290000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-130932000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-130932000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-130932000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72266000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.81
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72266000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.81
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72300000.0
Impax Laboratories Inc,IPXL,,0001003642,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:11:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.81
